Today: 19 May 2026
National Grid share price today: NG edges lower as UK rate-cut bets stay in focus
6 February 2026
1 min read

National Grid share price today: NG edges lower as UK rate-cut bets stay in focus

LONDON, Feb 6, 2026, 08:49 GMT — Regular session

National Grid (NG.L) shares edged slightly lower in early Friday trading, slipping 0.04% to 1,281.5 pence. The stock traded within a narrow range of 1,276.0 to 1,288.5 pence, hovering close to its 52-week peak of 1,300.5 pence.

The subdued shift follows the Bank of England’s decision to keep its benchmark rate steady at 3.75% in a narrow 5-4 vote, signaling it still plans to cut rates if inflation falls as expected. “All going well, there should be scope for some further reduction in Bank Rate this year,” Governor Andrew Bailey said. Reuters

This hits utilities hard since investors see them as bond stand-ins — reliable, regulated cash streams that react sharply to changes in discount rates and borrowing expenses. Even with little on the company docket, the sector can shift when rate-cut probabilities fluctuate.

National Grid closed Thursday at 1,282.0 pence, marking a 0.31% gain, LSEG data shows on Reuters.

London sentiment stayed cautious Thursday. The FTSE 100 dropped 0.9%, weighed down by bank shares reacting to the interest rate outlook. Sterling fell 0.76% as investors shifted their bets earlier toward the next rate cut. “It’s now merely a matter of timing,” said Matthew Ryan, head of market strategy at Ebury. Reuters

Company-specific headlines have been sparse. On Wednesday, a regulatory filing revealed that National Grid CEO Zoë Yujnovich received a five-year option on 3,292 ordinary shares through the group’s Sharesave employee scheme. The option is priced at £9.28 per share and becomes exercisable starting April 1, 2031.

Investors are taking cues from peers as UK network spending ramps up. SSE, a key UK utility, this week projected lower adjusted annual earnings compared to last year while pushing forward a five-year plan to upgrade Britain’s electricity grid. CFO Barry O’Regan emphasized the priority on “accelerating investment and delivering the plan.” Reuters

Utilities aren’t off the hook if the rate story shifts. Persistent inflation might push borrowing costs up and hold them there. Plus, regulatory clamps on permitted returns or unexpected expenses on major grid projects could quickly sour investor mood.

Traders will focus on UK rate-cut pricing, sterling, and gilts — UK government bonds — through the rest of Friday’s session to gauge where defensives land in portfolios following Thursday’s central bank divide.

National Grid’s next major event is the full-year results for 2025/26, set for May 14, according to its investor calendar. Final dividend dates are scheduled later that month.

Stock Market Today

  • Semtech Investment Growth: $1000 in 2015 Now Worth $3,821
    May 19, 2026, 9:55 AM EDT. If you had invested $1,000 in Semtech (SMTC) a decade ago, your stake would now be worth $3,821.31, representing a 282.13% gain. Semtech, based in Camarillo, California, designs and markets analog and mixed-signal semiconductors for commercial uses across infrastructure, high-end consumer, and industrial sectors. In fiscal 2025, it reported $909.3 million in revenue, up 4.7% year-over-year. Semtech's products serve data centers, consumer electronics, and industrial applications such as IoT and automotive systems. This growth highlights the rewards of long-term investment in semiconductor companies amid evolving technology demands.

Latest articles

Bakkt Up Early After Director Buys $4.85M in Shares

Bakkt Up Early After Director Buys $4.85M in Shares

19 May 2026
Bakkt shares jumped 14.2% to $9.96 in pre-market trading Tuesday after a filing showed director Michael Alfred’s vehicle bought $4.85 million in stock. SEC documents said Alfred acquired 585,000 shares last week via Alpine Fox LP. CEO Akshay Naheta exercised options for 33,557 shares at $10 each. Bakkt recently reported Q1 revenue of $243.6 million, down sharply from a year earlier.
Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

19 May 2026
Relay Therapeutics shares jumped 11.3% to $13.47 in premarket trading Tuesday after reporting a 60% volumetric response rate in 20 evaluable patients from its Phase 2 trial of zovegalisib for vascular anomalies. The company said 95% of patients saw some lesion reduction at 12 weeks. No patients discontinued due to adverse events. The regular Nasdaq session was set to open at 9:30 a.m. ET.

Popular

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.
Compass Group share price slips again as AI fears linger after Q1 update
Previous Story

Compass Group share price slips again as AI fears linger after Q1 update

Molina Healthcare stock sinks premarket after 2026 outlook miss, Medicare exit plan
Next Story

Molina Healthcare stock sinks premarket after 2026 outlook miss, Medicare exit plan

Go toTop